Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnixa Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
Anixa Biosciences, Inc. Earnings Date And Information
Anixa Biosciences, Inc. last posted its earnings results on Friday, January 10th, 2025. The company reported $-0.09 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Anixa Biosciences, Inc. has generated $0 earnings per share over the last year ($-0.39 diluted earnings per share) and currently has a price-to-earnings ratio of -7.25. Anixa Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based on prior year's report dates.
Anixa Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/11/2025 | Q1 2025 | N/A | -$0.10 | N/A | $0 | $0 |
| 01/10/2025 | Q4 2024 | -$0.11 | $0.30 | 0.41 | $0 | $0 |
| 09/06/2024 | Q3 2024 | -$0.11 | -$0.10 | 0.01 | $0 | $0 |
| 06/04/2024 | Q2 2024 | -$0.11 | -$0.10 | 0.01 | N/A | $0 |
| 03/12/2024 | Q1 2024 | -$0.09 | -$0.10 | -0.01 | N/A | $0 |
| 01/16/2024 | Q4 2023 | -$0.09 | -$0.09 | 0 | N/A | $156,000 |
| 09/06/2023 | Q3 2023 | -$0.09 | -$0.08 | 0.01 | N/A | $0 |
| 06/14/2023 | Q2 2023 | -$0.11 | -$0.07 | 0.04 | N/A | $210,000 |
| 03/16/2023 | Q1 2023 | N/A | -$0.07 | N/A | N/A | $0 |
| 01/04/2023 | Q4 2022 | -$0.13 | -$0.11 | 0.02 | N/A | $2.47 B |
| 07/31/2022 | Q3 2022 | N/A | -$0.09 | N/A | N/A | $0 |
| 06/10/2022 | Q2 2022 | -$0.13 | -$0.12 | 0.01 | N/A | $0 |
| 03/11/2022 | Q1 2022 | -$0.13 | -$0.13 | 0 | N/A | $0 |
| 01/04/2022 | Q4 2021 | N/A | -$0.13 | N/A | N/A | $3.61 M |
| 09/01/2021 | Q3 2021 | -$0.08 | -$0.14 | -0.06 | N/A | $0 |
| 06/10/2021 | Q2 2021 | -$0.10 | -$0.08 | 0.02 | N/A | $0 |
| 03/11/2021 | Q1 2021 | -$0.11 | -$0.09 | 0.02 | N/A | $512,500 |
| 01/07/2021 | Q4 2020 | N/A | -$0.09 | N/A | N/A | $-124,360 |
| 09/08/2020 | Q3 2020 | -$0.12 | -$0.11 | 0.01 | N/A | $0 |
| 06/09/2020 | Q2 2020 | -$0.12 | -$0.12 | 0 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anixa Biosciences, Inc. Earnings: FAQ's
Anixa Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based offlast year's report dates.
In the previous quarter, Anixa Biosciences, Inc. (:ANIX) reported $-0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.02.
The conference call for Anixa Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Anixa Biosciences, Inc.'s latest earnings report can be read online.
Anixa Biosciences, Inc. (:ANIX) has a recorded net income of $-12,554,000.Anixa Biosciences, Inc. has generated $-0.39 earnings per share over the last four quarters.
Anixa Biosciences, Inc. (:ANIX) has a price-to-earnings ratio of -7.25 and price/earnings-to-growth ratio is -0.11.